DON’T LET HAY FEVER GET UP YOUR NOSE THIS SUMMER

For millions with hay fever, summer means suffering from symptoms like sneezing, runny nose and itchy eyes. But it doesn’t have to be like that.

GRASS is a clinical research trial exploring long-term protection from the symptoms of hay fever.

Imperial College London is seeking men and women aged 18-65 to volunteer in the GRASS trial that is testing two currently available therapies for their long-term effectiveness in hay fever.

The GRASS trial will be conducted at Royal Brompton Hospital and Imperial College, London and led by Stephen Durham, MD – a leading specialist in allergies. The trial aims to test the long-term effectiveness of two commercially available hay fever treatments, Grazax® and Alutard SQ®.

The trial will begin between March and September 2011 and participants will remain in trial over a 3-year period, during which they will be provided with anti-allergy rescue medications including anti-histamines during the pollen season.

If eligible, you will receive medical advice about your hay fever as well as compensation for some study visits and travel expenses.

To find out more and register your interest, visit: www.hayfeverstudy.co.uk